Genomind
PrivateLast Round
Series D
Jan 29, 2021
Total Funding Raised
$20.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genomind is a precision health company that specializes in mental healthcare, providing genetic testing and a biotechnology platform to aid in personalized treatment. The company's main offerings, including the Genomind Professional PGx Express and the direct-to-consumer Mental Health Map, analyze a patient's genetic makeup to provide insights on how they may respond to different medications for psychiatric conditions. This enables healthcare professionals to reduce trial-and-error in medication selection and develop more targeted treatment plans. Founded in 2009 by Dr. Ronald Dozoretz, Genomind aims to optimize the treatment experience for individuals and providers through actionable genetic insights and innovative health technology.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Precision Medicine, Biotechnology, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomind Comparables
Compare Genomind with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Myriad Genetics | 86% | |
| Castle Biosciences, Inc. | 85% | |
| OneOme | 81% | |
Genomind Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jan 29, 2021 | ||||
| Series B | Feb 8, 2017 | ||||
| VC Round | Sep 22, 2015 | ||||
| Series A | Apr 9, 2014 |
Key People
Founding team and executive leadership
Genomind Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Claritas Capital | Series D, Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
Successfully treated over 500,000 patients.
Genomind Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |